LITAFD (Gene)

Entrez:101929989

Description:LITAF domain containing

Predicted to enable metal ion binding activity. Predicted to be located in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View LITAFD's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with LITAFD.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using LITAFD.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for LITAFD.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with LITAFD.

Results found

Linked to

	Label	Description
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE214931 2 V 0 TEMOZOLOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE217552 fisetin 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217552 3 V 4 FISETIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 0 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213291 GSE213294 GSK-J4 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680,GSE182683 0 V 12 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE213291 GSE213294 GSK-J4 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE204836 PP-3 1 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE214931 2 V 0 TEMOZOLOMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE217552 fisetin 3 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE217552 3 V 4 FISETIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 0 v 12 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE213291 GSE213294 GSK-J4 0 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182680,GSE182683 0 V 12 DEXAMETHASONE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE213291 GSE213294 GSK-J4 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 0 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE204836 PP-3 1 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.